From Lundbeck through Hospira to Hikma; the killing labs continue to improve their patients’ health!

May 15, 2013 - From Lundbeck through Hospira to Hikma

May 15, 2013 – From Lundbeck through Hospira to Hikma

The Pentobarbital experiment has moved to Propofol and now to Phenobarbital, once again thanks to a pharmaceutical laboratory, and better still a European one!

In its desperate killing quest, the state of Arkansas, where no one has been executed since 2005 and where 38 men await their death, purchased $20,000 worth of Phenobarbital via West-Ward Pharmaceuticals, a subsidiary of Hikma plc whose headquarters are based in London.

As it so happens, Hikma General Assembly will take place tomorrow, May 16th, at 16 Hanover Square in London.

While Hikma says its products cover key therapeutic areas focused on the patient, this newly found death market is becoming another key in its commercial strategies.

Tell Hana Ramadan at hramadan@hikma.com, Corporate Communication Director of Hikma the killing lab, how you feel about their choices and ask whether their shareholders are aware of the situation. No direct contact information seems available to contact the shareholders, so let’s share this via Twitter and Facebook:

#Hikma, the new death lab kills people #Darhold #SectoralAssetManagement

As the state of Arkansas attempts to use Phenobarbital to kill 3 persons in the near future, let’s not forget that the same state ranks nationally #45 in education, #48 in healthcare and #10 in incarceration rate.

State-sanctioned murders must stop now! Europe has a very clear position on the issue of the death penalty and European laboratories would be well advised to respect ethics and life in order to improve their patients’ health.

Please act and share this post NOW!

PentobarbitalX

About The Pentobarbital Experiment

"Lundbeck is a global pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for treatment of psychiatric and neurological disorders." As the sole supplier of Pentobarbital to US departments of corrections, Danish company Lundbeck took an active and dedicated part in the executions of human beings. This is a clear violation of its ethical obligations as a European pharmaceutical laboratory. Its manufacturing plant for Pentobarbital is based in Kansas, USA. Here is the full story: the facts and the numbers brought to you by European activists dedicated to the universal abolition of the death penalty. Disclaimer: This blog was created to raise awareness and to encourage legitimate citizen actions to bring an end to the torturous executions in the USA. It does not, and never did advocate violence or retaliation against whoever participates in the legal lynchings of human beings. View all posts by The Pentobarbital Experiment

2 responses to “From Lundbeck through Hospira to Hikma; the killing labs continue to improve their patients’ health!

  • Heinz Leitner

    Thanks Sandrine,

    Thanks for your inspiring fights. I have informed friends in Europe and the USA about the death profiteer Hikma and asked them to take urgent action too

    Kind regards from Austria

    Heinz

    _____

  • Heinz Leitner

    Dear Rainer, dear friends,
    As it so happens, Hikma General Assembly will take place today, May 16th, at 16 Hanover Square in London. This is why I have sent a “love letter” to them
    Solidarity
    Heinz
    To: ‘hramadan@hikma.com’; ‘mhammad@hikma.com’; ‘dshekem@hikma.com’

    Hana Ramadan
    Corporate Communication Director
    Hikma Pharmaceuticals PLC

    Maha Hammad
    Corporate Communication Supervisor
    Hikma Pharmaceuticals PLC

    Dana Shekem
    Marketing Communication Specialist
    Hikma Pharmaceuticals PLC

    Hana Ramadan,
    Ladies and Gentlemen,

    In its desperate killing quest, the state of Arkansas, where no one has been executed since 2005 and where 38 men await their death, purchased $20,000 worth of Phenobarbital via West-Ward Pharmaceuticals, a subsidiary of Hikma plc whose headquarters are based in London.

    As you know the execution of human beings is in contradiction to the European constitution and European values. This is why the European Commission and the European Parliament have imposed export restrictions on the sale of death drugs in the past.

    While Hikma says its products cover key therapeutic areas focused on the patient, this newly found death market is becoming another key in your commercial strategies obviously.

    Hana Ramadan, how do you feel about your choices, and your violation of European values and the constitution? Are your shareholders aware of the situation that Hikma will get a new trade mark as death profiteer in the public?

    You are aware that Europe will also impose export restrictions on your death drug like in previours cases.

    Because of your shameful behaviour Arkansas could buy your death drug before the export restrictions, and store Phenobarbital for executions in the future.

    You cannot wash your hands of it!

    Be sure that the European Commission, the European Parliament, the members of the national parliaments, and the public will be informed on the shameful behaviour of death profiteer Hikma!

    Heinz Leitner
    Vienna, Austria

%d bloggers like this: